Arkolith/Insider Trading/BIOA/Form 4

Rubin Paul D

Chief Medical OfficerBioAge Labs, Inc. (BIOA) · full profile →Form 4 · filed Dec 11, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$216K
Net Open-Market Flow
-$216K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 9, 2025Sell(S)18K$12.00$216K0
Dec 9, 2025Option exercise(M)18K$6.57$118K18K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 9, 2025Option exercise(M)18K—$09K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001210905-25-000006) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML